Generated by All in One SEO v4.9.10, this is an llms.txt file, used by LLMs to index the site.

# NETRI

Digitizing human biology

## Sitemaps

- [XML Sitemap](https://netri.com/sitemap.xml): Contains all public & indexable URLs for this website.

## Posts

- [NETRI JOINS DASSAULT SYSTEMS' 3DEXPERIENCE LAB PROGRAM TO ACCELERATE ITS INDUSTRIALIZATION](https://netri.com/netri-joins-dassault-systems-3dexperience-lab-program-to-accelerate-its-industrialization/) - A recognition of a breakthrough TechBio approach : NETRI is honored to have received the HealthTech Awards in the Techbio category, organized by France Biotech. This award, dedicated to emerging TechBio innovations, recognizes technologies at the intersection of biology, engineering and data science capable of transforming the future of healthcare innovation. For NETRI, this distinction acknowledges a foundational scientific and technological shift: the ability to measure human biology through function, using neurons as integrated biological sensors.
- [NETRI ouvre ses portes au grand public pour les Journées Choose France](https://netri.com/netri-ouvre-ses-portes-au-grand-public-pour-les-journees-choose-france/) - Les samedi 30 et dimanche 31 mai 2026, NETRI participera aux Journées Choose France, une initiative nationale portée par le Gouvernement visant à valoriser les entreprises qui investissent et produisent en France. À cette occasion, nous ouvrirons exceptionnellement les portes de nos unités de production d’organes sur puce à Lyon, au cœur du biodistrict de Gerland.
- [NETRI WINS THE FRANCE BIOTECH HEALTHTECH TROPHIES IN THE TECHBIO CATEGORY FOR ITS “NEURONS AS A SENSOR” PLATFORM.](https://netri.com/netri-wins-the-france-biotech-healthtech-trophies-in-the-techbio-category-for-its-neurons-as-a-sensor-platform/) - A recognition of a breakthrough TechBio approach : NETRI is honored to have received the HealthTech Awards in the Techbio category, organized by France Biotech. This award, dedicated to emerging TechBio innovations, recognizes technologies at the intersection of biology, engineering and data science capable of transforming the future of healthcare innovation. For NETRI, this distinction acknowledges a foundational scientific and technological shift: the ability to measure human biology through function, using neurons as integrated biological sensors.
- [World Health Day: improving predictivity to accelerate therapeutic innovation](https://netri.com/world-health-day-improving-predictivity-to-accelerate-therapeutic-innovation/) - NETRI remporte les Trophées de l'INPI France 2025 dans la catégorie Start-up des mains de Dominique Poiroux, Président de @HealthyNvest et Président du conseil d'admiistration de l'INPI France.
- [World Parkinson’s Day: advancing predictive models for neurodegenerative diseases](https://netri.com/world-parkinsons-day-advancing-predictive-models-for-neurodegenerative-diseases/) - NETRI remporte les Trophées de l'INPI France 2025 dans la catégorie Start-up des mains de Dominique Poiroux, Président de @HealthyNvest et Président du conseil d'admiistration de l'INPI France.
- [NETRI SELECTED FOR THE MERCK DIGITAL SCIENCES STUDIO (MDSS) INNOVATION PROGRAM.](https://netri.com/netri-selected-for-the-merck-digital-sciences-studio-mdss-innovation-program/) - As a Startup Ally, NETRI, a French TechBio company specializing in organs-on-chip technologies coupled with AI and predictive biological models, joins the MDSS ecosystem as a growth-stage company contributing through engagement with MSD experts, participation in ecosystem activities, and knowledge sharing with earlier-stage startups. Startup Allies serve as role models and emerging leaders within the MDSS ecosystem, contributing through engagement, knowledge sharing, and support to earlier-stage teams.
- [Les leaders du secteur annoncent la création de la première association mondiale dédiée aux systèmes microphysiologiques (IAMPS) - Une nouvelle voix commune pour un secteur stratégique pour l'Europe](https://netri.com/les-leaders-du-secteur-annoncent-la-creation-de-la-premiere-association-mondiale-dediee-aux-systemes-microphysiologiques-iamps-une-nouvelle-voix-commune-pour-un-secteur-strategique-pour-leurope/) - European microphysiological systems (MPS) industry leaders, AlveoliX (Switzerland); BiomimX (Italy); chiron (Netherlands) Dynamic42 (Germany); InSphero (Switzerland); MIMETAS (Netherlands) NETRI (France), React4Life (Italy) and TissUse (Germany), are announcing today the creation of the Industry Alliance for Microphysiological Systems (IAMPS), the world’s first industry association dedicated to represent MPS providers.
- [Industry Leaders Announce World’s First Microphysiological Systems Industry Association (IAMPS) - A new united voice for a strategic sector for Europe](https://netri.com/industry-leaders-announce-worlds-first-microphysiological-systems-industry-association-iamps-a-new-united-voice-for-a-strategic-sector-for-europe/) - European microphysiological systems (MPS) industry leaders, AlveoliX (Switzerland); BiomimX (Italy); chiron (Netherlands) Dynamic42 (Germany); InSphero (Switzerland); MIMETAS (Netherlands) NETRI (France), React4Life (Italy) and TissUse (Germany), are announcing today the creation of the Industry Alliance for Microphysiological Systems (IAMPS), the world’s first industry association dedicated to represent MPS providers.
- [NETRI remporte le Prix Innovation du prestigieux Prix Descroix-Vernier EthicScience](https://netri.com/prix-innovation-du-prestigieux-prix-descroix-vernier-ethicscience/) - NETRI remporte les Trophées de l'INPI France 2025 dans la catégorie Start-up des mains de Dominique Poiroux, Président de @HealthyNvest et Président du conseil d'admiistration de l'INPI France.
- [NETRI remporte les Trophées de l'INPI France 2025 dans la catégorie Start-up](https://netri.com/netri-remporte-les-trophees-de-linpi-france-2025-dans-la-categorie-start-up/) - NETRI remporte les Trophées de l'INPI France 2025 dans la catégorie Start-up des mains de Dominique Poiroux, Président de @HealthyNvest et Président du conseil d'admiistration de l'INPI France.
- [The Strategic Committee for Health Industries and Technologies (CSF ITS) publishes the 2025 White Paper on organoids and organs-on-chip: a roadmap for structuring a strategic French industry.](https://netri.com/f3oci-publishes-2025-white-paper-on-organoids-and-organs-on-chip/) - The Strategic Committee for Health Industries and Technologies (CSF ITS) announces the publication of the 2025 White Paper of the French Organoids and Organs on Chips Sector (F3OCI), a reference document that provides the first overview of the French sector and proposes a national strategy to position France among the world leaders in these disruptive technologies.
- [Le Comité Stratégique de Filière Industries et Technologies de Santé (CSF ITS) publie le Livre blanc 2025 sur les organoïdes et organes sur puce :une feuille de route pour structurer une filière stratégique française.](https://netri.com/f3oci-publie-son-livre-blanc-2025/) - Le Comité Stratégique de Filière Industries et Technologies de Santé (CSF ITS) annonce la publication du Livre blanc 2025 de la Filière Française des Organoïdes et Organes sur Puce (F3OCI), un document de référence qui dresse pour la première fois un panorama de la filière française et propose une stratégie nationale pour positionner la France parmi les leaders mondiaux de ces technologies de rupture.
- [Towards a quality control framework for cerebral cortical organoids: NETRI’s new publication in Nature Scientific Reports](https://netri.com/towards-a-quality-control-framework-for-cerebral-cortical-organoids-netris-new-publication-in-nature-scientific-reports/) - We are proud to share our latest scientific achievement, published in Nature Scientific Reports: “Towards a quality control framework for cerebral cortical organoids". This work addresses one of the major challenges in the field of organoid research: ensuring reproducibility and reliability through a standardized quality control (QC) framework for cerebral cortical organoids.
- [Functional discrimination of Alzheimer’s patients’ CSF using a Brain-on-Chip platform: NETRI’s new publication in Nature Scientific Reports](https://netri.com/functional-discrimination-of-alzheimers-patients-csf-using-a-brain-on-chip-platform-netris-new-publication-in-nature-scientific-reports/) - We are proud to share our latest scientific achievement, published in Nature Scientific Reports: “Functional discrimination of CSF from Alzheimer’s patients in a brain-on-chip platform” (read the article ). This work represents a major milestone for NETRI and our collaborators in advancing innovative technologies for the early diagnosis of neurodegenerative diseases.
- [NETRI remporte le prix de la Big Startup 2025](https://netri.com/netri-remporte-le-prix-de-la-big-startup-2025/) - Lundi soir, La French Tech Saint-Etienne Lyon organisait sa soirée annuelle Big Up, rassemblant tout l’écosystème tech et deeptech de la région. Un moment fort pour célébrer l’innovation, l’entrepreneuriat et les réussites collectives.
- [NETRI announces a partnership with ANSES to assess the neurotoxicity of pesticides](https://netri.com/netri-announces-a-partnership-with-anses-to-assess-the-neurotoxicity-of-pesticides/) - NETRI, Techbio neuro-organs-on-chip start-up, announces the signature of a scientific collaboration agreement with French Agency for Food, Environmental and Occupational Health and Safety (Anses). The aim of this joint research project is to develop new methods for assessing the toxicity of pesticides on the human nervous system, without recourse to animal testing.
- [NETRI annonce la signature d'un partenariat avec l'ANSES pour évaluer la neurotoxicité des pesticides](https://netri.com/netri-annonce-la-signature-dun-partenariat-avec-lanses-pour-evaluer-la-neurotoxicite-des-pesticides/) - NETRI, start-up industrielle Techbio de neuro-organes-sur-puce annonce la signature d’un accord de collaboration scientifique avec l’Agence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail (Anses). Ce projet de recherche commun vise au développement de nouvelles méthodes permettant l’évaluation de la toxicité des pesticides sur le système nerveux humain, sans recours aux tests sur animaux.
- [Revue de presse - Avril & Mai 2025](https://netri.com/revue-de-presse-avril-mai-2025/) - Reprise des actifs de la biotech HCS Pharma, Article dans un journal néerlandais, Prix DVES... Découvrez notre revue de presse du mois d'avril & mai 2025.
- [NETRI récompensée par Auvergne-Rhône-Alpes Entreprises](https://netri.com/netri-recompensee-par-auvergne-rhone-alpes-entreprises/) - NETRI récompensée par Auvergne-Rhône-Alpes Entreprises avec le Trophée Coup de cœur - Trophées d'Innovation Industrielle 2025.
- [FDA Announces Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs.](https://netri.com/fda-announces-plan-to-phase-out-animal-testing-requirement-for-monoclonal-antibodies-and-other-drugs/) - On April 10, the U.S. Food and Drug Administration (FDA) released a strategic roadmap to phase out the requirement for animal testing in the preclinical evaluation of monoclonal antibodies (mAbs) and other drugs.
- [NETRI ANNOUNCES ACQUISITION OF HCS PHARMA ASSETS TO STRENGHTEN ITS ONCOLOGICAL ADVERSE EVENTS PLATFORM](https://netri.com/netri-announces-acquisition-of-hcs-pharma-assets-to-strenghten-its-oncological-adverse-events-platform/) - NETRI, an industrial start-up specializing in neuro organs-on-chip combined with AI, announces the acquisition of HCS PHARMA assets. This strategic operation is fully in line with NETRI's development plan and strengthens its technological offering by integrating patented innovations in biomaterials and advanced cellular models.
- [NETRI ANNONCE L'ACQUISITION DES ACTIFS DE HCS PHARMA POUR RENFORCER SA PLATEFORME POUR LES EFFETS INDÉSIRABLES EN ONCOLOGIE](https://netri.com/netri-annonce-lacquisition-des-actifs-de-hcs-pharma-pour-renforcer-sa-plateforme-pour-les-effets-indesirables-en-oncologie/) - NETRI, start-up industrielle spécialisée dans les neuro organes sur puce combinés à l'IA, annonce l'acquisition des actifs de HCS PHARMA. Cette opération stratégique s'inscrit pleinement dans le plan de développement de NETRI et renforce son offre technologique en intégrant des innovations brevetées dans le domaine des biomatériaux et des modèles cellulaires avancés.
- [Les retombées médiatiques de l'inauguration de l'usine NETRI #2](https://netri.com/les-retombees-mediatiques-de-linauguration-de-lusine-netri-2/) - 10 jours après l'inauguration de l'usine NETRI, nous vous présentons les retombées médiatiques de cet événement.
- [Les retombées médiatiques de l'inauguration de l'usine NETRI](https://netri.com/les-retombees-mediatiques-de-linauguration-de-lusine-netri/) - 10 jours après l'inauguration de l'usine NETRI, nous vous présentons les retombées médiatiques de cet événement.
- [NETRI INAUGURE LA PREMIERE USINE FRANCAISE D’ORGANES-SUR-PUCE ET ANNONCE UNE LEVEE DE FOND DE 5 m€](https://netri.com/netri-inaugure-la-premiere-usine-francaise-dorganes-sur-puce-et-annonce-une-levee-de-fond-de-5-m/) - Basée sur une décennie de recherche académique, NETRI continue son ascension avec l’inauguration de son usine de production d’organes-sur-puce à Lyon, une première en France. Accompagnée d’une levée de fond de 5 m€, ce nouveau site marque un changement d’échelle pour la start-up industrielle, qui en six ans, est devenue un acteur référent sur l’ensemble du territoire et à l’international, dans le domaine de la recherche médicale et des technologies de santé.
- [NETRI INAUGURATES FRANCE'S FIRST ORGANS-ON-CHIP PLANT AND ANNOUNCES FUND RAISING OF €5 m](https://netri.com/netri-inaugurates-frances-first-organs-on-chip-plant-and-announces-fund-raising-of-5-m/) - Based on a decade of academic research, NETRI continues its ascent with the inauguration of its organs-on-chip production plant in Lyon, a first in France. Accompanied by €5m fund-raising, this new site marks a change of scale for the industrial start-up, which in just six years has become a key player throughout France and internationally, in the field of medical research and healthcare technologies.
- [NETRI at the Hôtel de Région of Lyon for a press conference.](https://netri.com/netri-at-the-hotel-de-region-of-lyon-for-a-press-conference/) - The morning of Monday November 25 was dedicated to CES Las Vegas 2025, with a press conference, the final preparatory meeting and a meeting of the 2025 delegation at the Hôtel de Région in Lyon, organized by the Auvergne-Rhône-Alpes Region and Minalogic.
- [NETRI présent à l'Hôtel de Région de Lyon pour une conférence de presse](https://netri.com/netri-present-a-lhotel-de-region-de-lyon-pour-une-conference-de-presse/) - La matinée du lundi 25 novembre était sous le signe du CES Las Vegas 2025 avec l'organisation d'une conférence de presse, la dernière réunion de préparation et la rencontre de la délégation 2025 à l'Hôtel de Région de Lyon, organisé par la Région Auvergne-Rhône-Alpes et Minalogic.
- [NETRI Wins Prestigious Innovation Award From Consumer Electronic Show (CES) 2025 In The Food AgTech Category.](https://netri.com/netri-wins-prestigious-innovation-award-from-consumer-electronic-show-ces-2025-in-the-food-agtech-category/) - NETRI, an industrial start-up based in Lyon (France), has been awarded the highly coveted Innovation Award from CES Las Vegas for its pioneering platform, NeuroFluidics™ Care. This platform is transforming biochemical safety assessments, enabling early toxicity analysis of compounds used by the food industry with unprecedented precision and accessibility.
- [OCTOBER 2024 NEWSLETTER](https://netri.com/october-2024-newsletter/) - We're excited and proud to launch our new quarterly newsletter! To make sure you receive it, please sign up.
- [The first letter of intent into CDER' ISTAND Pilot Program for organs-on-chip technology.](https://netri.com/the-first-letter-of-intent-into-its-istand-pilot-program-for-organs-on-chip-technology/) - The FDA's Center for Drug Evaluation and Research (CDER) has accepted the first letter of intent (LOI) into its ISTAND Pilot Program for organs-on-chip technology. This LOI is for a human Liver-Chip used to assess the risk of DILI in adults to create relevant data for a drug’s investigational new drug (IND) submission. This LOI acceptance marks a major step forward for CIVM in general.
- [NETRI announces the formation of its Scientific Advisory Board.](https://netri.com/netri-announces-the-formation-of-its-scientific-advisory-board/) - NETRI, an industrial start-up that develops organs-on-chip for health industries, today announced the formation of its Scientific Advisory Board (SAB) and inaugural appointment of Dr. Myriam Guiral and Dr. Nicolas Aznar. The SAB members will provide insight and guidance to NETRI on the scientific orientation. Today, NETRI's SAB is meeting for the first time with NETRI teams to benefit from their unique insight in Oncology and Organoids state of the art and markets.
- [NETRI annonce la formation de son Conseil Scientifique (Scientific Advisory Board).](https://netri.com/netri-annonce-la-formation-de-son-conseil-scientifique-scientific-advisory-board/) - NETRI, une start-up industrielle qui développe des organes sur puce pour les industries de la santé, annonce aujourd'hui la formation de son Conseil Scientifique (SAB) et la nomination inaugurale du Dr Myriam Guiral et du Dr Nicolas Aznar. Les membres du SAB fourniront à NETRI des informations et des conseils sur l'orientation scientifique. Aujourd'hui, le SAB de NETRI se réunit pour la première fois avec les équipes NETRI afin de partager leur vision unique de l'état de l'art et des marchés en l'oncologie et culture en 3D (organoïdes).
- [World Precision Instruments and NETRI Announce their Partnership to Enable Transepithelial Electrical Resistance for Organs-on-Chip Technology.](https://netri.com/world-precision-instruments-and-netri-announce-their-partnership-to-enable-transepithelial-electrical-resistance-for-organs-on-chip-technology/) - World Precision Instruments (WPI), a leading provider of high-quality laboratory instruments and equipment for basic research and drug development, and NETRI, an organs-on-chip industrial start-up, are proud today to announce their partnership. This partnership aims to associate WPI's transepithelial electrical resistance (TEER) technology, and products enabling TEER, with NETRI's proprietary NeoBento organs-on-chip MultiFluidics™ line.
- [BioValley France et France Biotech pilotent les travaux du CSF sur les organoïdes et les organes sur puces en France](https://netri.com/biovalley-france-et-france-biotech-pilotent-les-travaux-du-csf-sur-les-organoides-et-les-organes-sur-puces-en-france/) - BioValley France, chef de file de la filière O&OoC et représentant d’Enosis Santé, représenté par Jean-Dominique Guitton, et France Biotech représentée par Thibault Honegger, co-fondateur et PDG de NETRI, start-up industrielle d’organes sur puce, s’unissent pour dynamiser le groupe de travail « Organoïdes et organes sur puces ». L’objectif : créer une force collective et proposer des actions concrètes pour animer et mettre en avant l’intérêt de structuration de la filière conformément aux attentes du projet 14.
- [NETRI participates to the Centre for Animal-Free Biomedical Translation funding by The Dutch National Growth Fund with 124.5 million euros.](https://netri.com/netri-participated-to-the-centre-for-animal-free-biomedical-translation-funding-by-the-dutch-national-growth-fund-with-124-5-million-euros/) - A new Dutch initiative to accelerate the transition to animal-free biomedical innovations.
- [Press review of the month](https://netri.com/press-review-of-the-month/) - There's a lot going on in the world of organs-on-chip this month.
- [Récapitulatif presse du mois](https://netri.com/recapitulatif-presse-du-mois/) - Ca bouge énormément dans le monde des organes sur puce ce mois-ci.
- [« Puces: les différentes faces de l’Hexagone. » NETRI mis à l’honneur dans ce 153ème numéro du magazine ELECTRONIQUES dans la catégorie la start-up du mois.](https://netri.com/puces-les-differentes-faces-de-lhexagone-netri-mis-a-lhonneur-dans-ce-153eme-numero-du-magazine-electroniques-dans-la-categorie-la-start-up-du-mois/) - Rendez-vous page 45-46 pour découvrir comment NETRI, à la frontière entre la microélectronique, microfluidique et biologie, reproduit la biologie humaine sur puce. Plongez dans notre univers d’innovation et d’industrialisation au travers ce super article rédigé par Alicia Aloisi.
- [Axol Bioscience and NETRI sign product supply agreement.](https://netri.com/axol-bioscience-and-netri-sign-product-supply-agreement/) - We're excited to announce the signing of a product supply agreement between Axol Bioscience and NETRI to supply Organs-on-chip (OoC) kits including device and human iPSC for pre-clinical neuroscience research, cosmetics and drug discovery. This exciting agreement paves the way for future co-development work between NETRI, an OoC provider and Axol Bioscience, a leading supplier of iPSC-derived cells for advanced in vitro platforms.
- [France 2030 apporte son soutien aux start-ups industrielles en soutenant NETRI et son projet Axone dans le cadre du dispositif "Nouvelle Usine"](https://netri.com/france-2030-apporte-son-soutien-aux-start-ups-industrielles-en-soutenant-netri-et-son-projet-axone-dispositif-nouvelle-usine/) - NETRI annonce aujourd’hui être lauréat de l’appel à projet « Première Usine » de France 2030.
- [NETRI remporte le Prix EY Coup de coeur du Jury - Catégorie Start-up de l'Année](https://netri.com/netri-laureate-prix-ey-coup-de-coeur-2022/) - Retour sur la cérémonie du Prix EY de l'Entrepreneur de l'Année pour la région Auvergne-Rhône-Alpes.
- [NETRI, start-up industrielle lyonnaise, bénéficie du soutien financier de la région Auvergne-Rhône-Alpes grâce au dispositif « Pack relocalisation – Former les salariés ».](https://netri.com/netri-start-up-industrielle-lyonnaise-beneficie-du-soutien-financier-de-la-region-auvergne-rhone-alpes-grace-au-dispositif-pack-relocalisation-former-les-salaries/) - NETRI est fier d’annoncer l’obtention du soutien financier de la @Région Auvergne Rhône Alpes â travers le programme « Pack relocalisation – Former les salariés ». Ce financement vient s’inscrire dans le cadre du plan de développement industriel et de formation de la région.
- [Thibault Honegger, PDG et Co-Fondateur de NETRI, dans Le Magazine Biovalley France](https://netri.com/thibault-honegger-pdg-et-co-fondateur-de-netri-dans-le-magazine-biovalley-france/) - 1 question, 4 experts dans Le Magazine Biovalley France Les organes-sur-puce vont-ils révolutionner la santé ? La réponse de Thibault Honegger, PDG et Co-Fondateur de NETRI.
- [NETRI introduces new exclusive package: Organs-on-chip kits](https://netri.com/netri-launches-organs-on-chip-kits/) - Designed to enable the swift and seamless integration of organs-on-chips into the research processes of the healthcare industry, our organs-on-chisp kits provide highly relevant in vitro models with larger, faster and more predictive datasets.
- [NETRI, nouvel adhérent French Tech](https://netri.com/netri-adherent-french-tech/) - C'est avec grande fierté que NETRI, start-up industrielle, rejoint la communauté de la French Tech Saint-Etienne Lyon en tant qu'adhérent.
- [NETRI, en collaboration avec Axion BioSystems, lance sa nouvelle gamme NeuroFluidics™ MEA, des organes-sur-puce haut débits compatibles avec la technologie MEA](https://netri.com/netri-lance-sa-nouvelle-gamme-neurofluidics-mea/) - NETRI présente la première gamme commerciale et mondiale d’organes-sur-puce haut débits compatible avec la technologie MEA (MicroElectrode Array), NeuroFluidics™ MEA. Cette gamme est composée de trois dispositifs microfluidiques compartimentés, intégrant la technology MEA d’Axion BioSystems et compatibles avec les systèmes d’enregistrement Maestro Pro et Maestro Edge.
- [NETRI, in collaboration with Axion BioSystems, launches NeuroFluidics™ MEA line, high-throughput MEA-capable organs-on-chip.](https://netri.com/netri-launches-neurofluidics-mea-new-line/) - NETRI introduces the world’s first commercially available MEA-capable organs-on-chip line, NeuroFluidics™ MEA, composed of three compartmentalized microfluidic devices powered by Axion Biosystems' integrated MEA technology and compatible with Maestro Pro and Maestro Edge systems.
- [NETRI lauréat des Grands Prix Check Up Santé, catégorie Start-up santé, organisés par BFM Business](https://netri.com/netri-laureat-des-grands-prix-check-up-sante-categorie-start-up-sante-organises-par-bfm-business/) - Le mercredi 19 avril NETRI s'est vu remettre le prix Start up santé des Grands Prix Check up Santé de BFM Business par Yann Lhuissier, Directeur Marchés et Clients chez LCL.
- [France 2030 apporte son soutien aux « Innovations en biotherapies et bioproduction » en sélectionnant le consortium industriel NETRI et ETAP-Lab.](https://netri.com/france-2030-apporte-son-soutien-aux-innovations-en-biotherapies-et-bioproduction-en-selectionnant-le-consortium-industriel-netri-et-etap-lab/) - A l’occasion de la deuxième édition de son concours de pitchs de startups Le Pitch Care, dont la finale se tenait mercredi 29 mars, l’association des Acteurs de La French Care a eu l’honneur de décerner le prix du lauréat à la startup industrielle lyonnaise NETRI.
- [NETRI grand gagnant de la deuxième édition du Pitch Care, organisée par Les Acteurs de La French Care](https://netri.com/netri-grand-gagnant-de-la-deuxieme-edition-du-pitch-care-organisee-par-la-french-care/) - A l’occasion de la deuxième édition de son concours de pitchs de startups Le Pitch Care, dont la finale se tenait mercredi 29 mars, l’association des Acteurs de La French Care a eu l’honneur de décerner le prix du lauréat à la startup industrielle lyonnaise NETRI.
- [Semaine du cerveau 2023 | 25ème édition](https://netri.com/semaine-du-cerveau-2023-25eme-edition/) - Une semaine sous le signe des avancées de la recherche en neurosciences. L’occasion pour le public et grand public de trouver des réponses à leurs questions !
- [NETRI a eu le plaisir de recevoir Jean-Noël Barrot, Ministre Délégué chargé de la Transition numérique et des Télécommunications](https://netri.com/netri-a-eu-le-plaisir-de-recevoir-jean-noel-barrot-ministre-delegue-charge-de-la-transition-numerique-et-des-telecommunications/) - Une rencontre au cœur de nos laboratoires, au sein du centre d'innovation de Lyonbiopôle, rythmée par un échange autour de notre industrialisation, de ses challenges et de ses perspectives.
- [NETRI and Axol Bioscience announce their partnership](https://netri.com/netri-and-axol-bioscience-announce-their-partnership/) - NETRI and Axol Bioscience announce a strategic partnership to launch organs-on-chip kits including both NETRI’s neuro-organs-on-chip devices and Axol’s human induced pluripotent stem cells (hiPSC) with reagents to boost pharmaceutical industry access to organs on chip.
- [NETRI participates in J.P. Morgan Healthcare Week](https://netri.com/netri-participates-in-j-p-morgan-healthcare-week/) - From January 9 to 11, 2023, meet our CEO & Co-Founder Thibault Honegger at Business France North America's French Healthcare Corner, located at Café Bastille in San Francisco.
- [NETRI wishes you a happy new year 2023](https://netri.com/netri-finaliste-de-la-17eme-edition-des-trophees-bref-eco-2/) - After a year of innovation in 2022, we look forward to presenting all our new projects in 2023
- [Tessara Therapeutics and NETRI to collaborate on the development of next generation 3D brain-on-a-chip model](https://netri.com/tessara-therapeutics-and-netri-to-collaborate-on-the-development-of-next-generation-3d-brain-on-a-chip-model/) - Tessara and NETRI will collaborate to combine the RealBrain® neural micro-tissues with the NeoBentoTM high-throughput microfluidic platform. The combination of the physiological relevance of fully functional 3D neural micro-tissues with the high-throughput microfluidics platform is expected to deliver a family of next generation drug discovery tools.
- [NETRI finaliste de la 17ème édition des Trophées Bref Eco](https://netri.com/netri-finaliste-de-la-17eme-edition-des-trophees-bref-eco/) - Après avoir remporté le prix Coup de cœur du jury en 2019, nous sommes fiers d'être cette année encore parmi les finalistes dans la catégorie santé et industrie de la 17ème édition des Trophées Bref Eco.
- [The FDA Modernization Act of 2021 just passed the Senate](https://netri.com/the-fda-modernization-act-of-2021-just-passed-the-senate/) - NETRI is please to acknowledge US Senate approvale of The FDA Modernization Act of 2021!
- ["Capabilities lunch" LinkedIn live webinars](https://netri.com/capabilities-lunch-linkedin-live-webinars/) - We are excited to announce that we are launching our first "Capabilities lunch" LikedIn live webinars! Discover the program.
- [NETRI aux BioTuesdays](https://netri.com/netri-aux-biotuesdays/) - NETRI a présenté ses activités lors des traditionnels Biotuesdays organisés par la Metropole de Lyon au café InSted, 6 rue de la Part Dieu, 69006, le mardi 7 Janvier 2020.
- [NETRI soutenu par les Hospices Civils de Lyon et Lyonbiopole](https://netri.com/netri-soutenu-par-les-hopices-civil-de-lyon-et-lyonbiopole/) - NETRI est lauréat de l’appel à projets Innovation Clinique porté par les Hospices Civils de Lyon et Lyonbiopôle.Porté conjointement par la société NETRI et la biologiste praticien hospitalier Isabelle QuadrioS’intéressant au diagnostic des patients atteints de troubles neurocognitifs (Alzheimer, démences à Corps de Lewy ou encore Parkinson), ce projet propose de développer un dispositif neurofluidique
- [La Région Auvergne-Rhône-Alpes soutient NETRI](https://netri.com/la-region-auvergne-rhone-alpes-soutient-netri/) - La Région Auvergne-Rhône-Alpes a répondu favorablement à NETRI dans le cadre de l’opération « Financement d’une prestation d’accompagnement conseils dans le cadre du dispositif Ambition Innovation – Être accompagné dans mon projet « Industrie future ».
- [Electrokinetic confinement of axonal growth for dynamically configurable neural networks](https://netri.com/electrokinetic-confinement-of-axonal-growth-for-dynamically-configurable-neural-networks/) - Abstract Axons in the developing nervous system are directed via guidance cues, whose expression varies both spatially and temporally, to create functional neural circuits. Existing methods to create patterns of neural connectivity in vitro use only static geometries, and are unable to dynamically alter the guidance cues imparted on the cells. We introduce the use of AC electrokinetics to
- [Microfluidic neurite guidance to study structure-function relationships in topologicallycomplex population-based neural networks](https://netri.com/microfluidic-neurite-guidance-to-study-structure-function-relationships-in-topologicallycomplex-population-based-neural-networks/) - ABSTRACT The central nervous system is a dense, layered, 3D interconnected network of populations of neurons,and thus recapitulating that complexity for in vitro CNS models requires methods that can createdefined topologically-complex neuronal networks. Several three-dimensional patterning approacheshave been developed but none have demonstrated the ability to control the connections betweenpopulations of
- [Stay informed !](https://netri.com/stay-informed/) - We are pleased to present the NETRI Newsletter. Be the first to know about the lastest published papers using neurofluidics chips,the upcoming conferences in the field,our new scientific achievements. Subscribe and stay informed !
- [Development of a high-throughput arrayed neural circuitry platform using human induced neurons for drug screening applications](https://netri.com/development-of-a-high-throughput-arrayed-neural-circuitry-platform-using-human-induced-neurons-for-drug-screening-applications/) - AbstractProper brain function relies on the precise arrangement and flow of information between diverse neural subtypes. Developing improved human cell-based models which faithfully mimic biologically relevant connectivity patterns may improve drug screening efforts given the limited success of animal models to predict safety and efficacy of therapeutics in human clinical trials. To address this need,
- [NETRI is mobilizing against Covid-19](https://netri.com/netri-is-mobilizing-against-covid-19/) - NETRI is responding to the European Commission’s request to print masks using filtration fabrics with its 3D printer pools for hospitals. NETRI répond à l’appel de la Commission Européenne et imprime des masques utilisant des tissus filtrants grâce à son pool d’imprimantes 3D pour les hôpitaux.
- [Breackthrough unlocks progress in brain-on-a-chip technology](https://netri.com/breackthrough-unlocks-progress-in-brain-on-a-chip-technology/) - Press ReleaseMarch 25th, 2020 Breackthrough unlocks progress in brain-on-a-chip technology Massively accelerated image processing supports development of novel treatments for neurological conditions Lyon, March 25, 2020 – Cambridge Consultants and Neuro Engineering Technologies Research Institute (NETRI) announce a breakthrough in precision imaging of brain activity. Working with NETRI’s brain-on-a-chip technology and lensless imaging approach that detects
- [Research on SRAS-CoV-2 influence on the nervous system](https://netri.com/research-on-sras-cov-2-influence-on-the-nervous-system-2/) - NETRI offers free samples for research teams that are working on SRAS-CoV-2 interactions with the central/peripheral nervous system. Neurofluidic™ chips allow fluid isolation of neural types to study the spread of the virus through synaptic chambers.Contact us ASAP!Coronavirus humains respiratoires neuro-invasifs et neurotropes : agents neurovirulents potentiels. Marc Desforges, Alain Le Coupanec, Élodie Brison, Mathieu Meessen-Pinard,
- [NETRI received the Global Health & Pharma’s 2020 Biotechnology Awards](https://netri.com/netri-received-the-global-health-pharmas-2020-biotechnology-awards-2/) - NETRI is honored to receive the Global Health Pharma's Biotechnology Award 2020.
- [NETRI mis en avant dans Les Echos](https://netri.com/netri-mis-en-avant-dans-les-echos-3/) - L'article paru dans Les Echos met en avant NETRI et ses projets de développement.
- [NETRI PRÉSENTÉ DANS LA GAZETTE DU LABORATOIRE](https://netri.com/netri-presente-dans-la-gazette-du-laboratoire-2/) - La Gazette du Laboratoire consacre un article à Netri dans son n°273 de Mars 2021.
- [Vers une révolution de la recherche pharmaceutique](https://netri.com/vers-une-revolution-de-la-recherche-pharmaceutique/) - NETRI présente ses technologies de cerveau sur puce à la délégation officielle dans le cadre du salon Global Industrie
- [New Communication campaign](https://netri.com/1technonetri/) - NETRI has developed key and unique technologies that allow to produce reproducible, close to human physiopathology, reliable and easy to use organ-on-chip!
- [La start-up industrielle NETRI lance son propre logiciel de gestion de production](https://netri.com/la-start-up-industrielle-netri-lance-son-propre-logiciel-de-gestion-de-production/) - NETRI déploie son logiciel de production, GESPROD, dans l’unité pilote de production.
- [L'accélération de l'industrialisation de la start-up industrielle NETRI - Le Mag Eco](https://netri.com/lacceleration-de-lindustrialisation-de-la-start-up-industrielle-netri-le-mag-eco/) - Thibault Honegger, Président et Co-Fondateur de NETRI, présente l'industrialisation de sa start-up industrielle dans le magasine Le Mag Eco de la CCI Lyon Métropole.
- [Building the Nervous System-on a Chip, in collaboration with Axol Bioscience](https://netri.com/building-the-nervous-system-on-a-chip-in-collaboration-with-axol-bioscience/) - Discover how NETRI's innovative organ-on-a-chip (OoC) devices enable the recreation of human neural circuits with hiPSCs for drug discovery assays, around a Q&A with Axol Bioscience.
- [NETRI sponsors the Microphysiological Systems World Summit 2022 hybrid conference](https://netri.com/netri-sponsors-the-microphysiological-systems-world-summit-2022-hybrid-conference/) - NETRI sponsor of the Microphysiological Systems World Summit 2022 hybrid conference that will take place from May 30th to June 3rd in New Orleans, LA.
- [NETRI present at the international conference SLAS2022 with a poster co-authored with BrainXell](https://netri.com/netri-present-at-the-international-conference-slas2022-with-a-poster-co-authored-with-brainxell/) - NETRI has written a poster in collaboration with the human induced pluripotent stem cells supplier BrainXell, available in the SLAS2022 international conference, "Modeling the human Brain-on-Chip with human iPSC-derived Glutamatergic neurons". Poster #1159-D and booth #2029
- [NETRI présentée dans le JT 19/20 du 9 Février 2022 de France 3 Rhône-Alpes par Frédéric Llop et Marie Redortier](https://netri.com/netri-presentee-dans-le-jt-19-20-du-9-fevrier-2022-de-france-3-rhone-alpes-par-frederic-llop-et-marie-redortier/) - NETRI est présentée par Frédéric Llop et Marie Redortier au JT de France 3 Région à travers une interview de Thibault Honegger, PDG & Co-Fondateur et une visite de ses laboratoires de production et de biologie cellulaire.
- [NETRI launches its first product line: NeuroFluidics™](https://netri.com/netri-launches-its-first-product-line-neurofluidics/) - NETRI has developed key and unique NeuroFluidics™ products that allow to challenge the way we discover new treatments with a mutlidisciplinary, simple to use and user friendly approach!
- [The Lyon-based industrial start-up NETRI finalizes a Series A of €8 million fundraising round.](https://netri.com/the-lyon-based-industrial-start-up-netri-finalizes-a-series-a-of-e8-million-fundraising-round/) - The Lyon-based industrial start-up NETRI finalizesa Series A of €8 million fundraising round.This financing will allow NETRI to accelerate the development of its pilot production units for microfluidic devices and human-cell cultures in order to support its growth, become the world industrial leader in organs-on-chip and to expand its fields of application. NETRI develops innovative
- [La start-up industrielle lyonnaise NETRI finalise un tour de table de série A de 8 millions d’euros.](https://netri.com/la-start-up-industrielle-lyonnaise-netri-finalise-un-tour-de-table-de-serie-a-de-8-millions-deuros/) - La start-up industrielle lyonnaise NETRI finaliseun tour de table de série A de 8 millions d’euros. Ce financement permettra à NETRI d’accélérer le développement de ses unités de production pilotes de dispositifs microfluidiques et de cultures cellulaires humaines afin de soutenir sa croissance, devenir le leader mondial industriel d’organes-sur-puce et d’étendre ses domaines d’applications. NETRI
- [NETRI in 5 Top Emerging Organ-on-a-Chip (OOC) Startups Impacting The Pharma Sector](https://netri.com/netri-in-5-top-emerging-organ-on-a-chip-ooc-startups-impacting-the-pharma-sector/) - NETRI in 5 Top Emerging Organ-on-a-Chip (OOC) Startups Impacting The Pharma Sector by StartUs Insight
- [NETRI sera présent à la prochaine édition de "1 verre 1 job" de H7, le jeudi 17 mars](https://netri.com/netri-sera-present-a-la-prochaine-edition-de-1-verre-1-job-de-h7-le-jeudi-17-mars/) - NETRI sera présent à la prochaine édition de "1 verre 1 job" de H7, le jeudi 17 mars
- [NETRI a été audité le jeudi 10 mars 2022 par l'ANSM lors du Comité Sécurité et qualité des médicaments - Formation restreinte sécurité non-clinique](https://netri.com/netri-a-ete-audite-le-jeudi-10-mars-2022-par-lansm-lors-du-comite-securite-et-qualite-des-medicaments-formation-restreinte-securite-non-clinique/) - L'occasion pour NETRI et ses experts scientifiques de présenter sa vision et le rôle des organes-sur-puce dans le développement de nouveaux médicaments.
- [NeoBento™ : new container for NETRI microfluidic chips](https://netri.com/neobento-new-container-for-netri-microfluidic-chips/) - NETRI launches its new organs-on-chip container, called NeoBento™! The future of organs-on-chip starts here, with our new NeoBento™ that combines reproducibility, versatility and simplicity.
- [NETRI présentée dans Capital, édition "Réussite à la française"](https://netri.com/netri-presentee-dans-capital-edition-reussite-a-la-francaise/) - "Réussite à la française" de CAPITAL, comment NETRI répond aux enjeux de santé actuels et futurs.
- [Let's go for the MPS World Summit 2022 congress!](https://netri.com/lets-go-for-the-mps-world-summit-2022-congress/) - Our CEO & Co-Founder Thibault Honegger and our R&D & Equipment Director Serge Roux are waiting for you at booth #110! Come and discover our innovative organs-on-chip solutions and its applications. Booth #110
- [NETRI acteur de La French Care](https://netri.com/netri-acteur-de-la-french-care/) - NETRI, industriel de neuro-organes-sur-puce, membre de la communauté La French Care.
- [NETRI dans le dernier BIOTECHFINANCES #989](https://netri.com/netri-dans-le-dernier-biotechfinances-989/) - "NETRI prépare un saut de géant dans les neuro-organes sur puces.", le dernier BIOTECHFINANCES #989 par Nathaly Mermet.
- [Meet us at EUROoCS 2022 congress in Grenoble, France!](https://netri.com/meet-us-at-euroocs-2022-congress-in-grenoble-france/) - NETRI team at EUROoCS 2022 congress in Grenoble, France!
- [NETRI as an exhibitor at the 2nd workshop on next gen organ-on-chip & organoids by CSEM](https://netri.com/netri-as-an-exhibitor-at-the-2nd-workshop-on-next-gen-organ-on-chip-organoids-by-csem/) - NETRI team at the 2nd workshop on next gen organ-on-chip & organoids, Geneva!
- [NETRI dans le Sucess Stories de Juin 2022, La Gazette du Laboratoire](https://netri.com/netri-dans-le-sucess-stories-de-juin-2022-la-gazette-du-laboratoire-2/) - NETRI dans le Sucess Stories de Juin 2022, La Gazette du Laboratoire - Focus sur NETRI une réussite lyonnaise
- [La start-up industrielle lyonnaise NETRI membre du Cluster EDEN (European Defense Economic Network)](https://netri.com/la-start-up-industrielle-lyonnaise-netri-membre-du-cluster-eden-european-defense-economic-network/) - NETRI, acteur industriel français d’organes-sur-puce, a retenu l’attention de l’association Cluster EDEN et fait désormais parti de ses membres.
- [NETRI and Axion BioSystems announce organs-on-chip collaboration.](https://netri.com/netri-and-axion-biosystems-announce-organs-on-chip-collaboration/) - NETRI and Axion BioSystems announce a collaboration to develop MEA-capable compartmentalized microfluidic devices. This joint venture provides the pre-clinical field with the ability to evaluate electrophysiological connectivity between neurons and other cell populations.
- [NETRI member of the North American 3Rs Collaborative’s (NA3RsC) Compassion Fatigue Resiliency initiative.](https://netri.com/netri-member-of-the-north-american-3rs-collaboratives-na3rsc-compassion-fatigue-resiliency-initiative/) - NETRI, industrial start-up, becomes a member of the NA3RsC initiative.
- [Deposition chamber technology as building blocks for a standardized brain-on-chip framework](https://netri.com/deposition-chamber-technology-as-building-blocks-for-a-standardized-brain-on-chip-framework/) - In vitro modeling of human brain connectomes is key to explore the structure-function relationship of the centralnervous system. The comprehension of this intricate relationship will serve to better study the pathological mechanismsof neurodegeneration, and hence to perform improved drug screenings for complex neurological disorders, such asAlzheimer’s and Parkinson’s diseases. However, currently used in vitro modeling
- [Microchannel patterning strategies for in vitro structural connectivity modulation of neural networks](https://netri.com/microchannel-patterning-strategies-for-in-vitro-structural-connectivity-modulation-of-neural-networks/) - AbstractCompartmentalized microfluidic chips have demonstrated tremendous potential to create in vitro minimalistic environments for the reproduction of the neural circuitry of the brain. Although the protocol for seeding neural soma in these devices is well known and has been widely used in myriad studies, the accurate control of the number of neurites passing through the
- [Neurite growth kinetics regulation through hydrostatic pressure in a novel triangle-shaped neurofluidic system](https://netri.com/neurite-growth-kinetics-regulation-through-hydrostatic-pressure-in-a-novel-triangle-shaped-neurofluidic-system/) - AbstractMicrofluidic neuro-engineering design rules have been widely explored to create in vitro neural networks with the objective to replicate physiologically relevant structures of the brain. Several neurofluidic strategies have been reported to study the connectivity of neurons, either within a population or between two separated populations, through the control of the directionality of their neuronal

## Pages

- [Innervate.Screen.Translate.](https://netri.com/) - Enhancing human healththrough the discriminating powerof the nervous system. CLINICAL FORESIGHT WAY AHEAD OF SCHEDULE PREDICT KEY RISK-BENEFIT RATIO SOONER THAN EVER POSSIBLE BEFORE USING OUR NEURONS AS A SENSOR METHOD : WILL MY CANCER TREATMENT HAVE SIDE EFFECTS?WILL MY THERAPY INDUCE AN IMMUNE RESPONSE?IS MY COMPOUND NEUROTOXIC?WILL MY CREAM ITCH? Results projected in 2-dimensionsfrom
- [NETRI Cloud Privacy Policy](https://netri.com/netri-cloud-privacy-policy/) - NETRI CLOUDPrivacy Policyv1.1 Last update 17 June 2026NETRI (Our Company) is a French company working in the Biotech domain, which is the publisher of Netri.cloud digital platform that offers services to help discriminate chemical compounds on their effects measured on NETRI proprietary Organs-on-a-Chip testing platform.This GDPR compliant privacy policy explains how NETRI uses the personal
- [Resources Hub](https://netri.com/resources-hub/) - RESOURCES HUB. 150+ resources with our organs-on-chip and digital library technologies. 70+ Publications 10+ Use Cases 20+ Webinars 15+ Protocols Publications Bessy, T.; Martinez, A.; Baquerre, C.; Grégoire, C. ; Batut, A.; Berthelin, A.; Dubuisson, L.;Teluob, S.; Azéma, A.; Roussel Berlier, L.; Lelièvre, D.; and Guichard, A. (2026). An in vitro organ-on-chip model for studying neuron–keratinocyte
- [UpLink+ Help](https://netri.com/uplink-plus-help/) - UPLINK+ HELP. INTRODUCTION COMPARTMENTALIZED ELECTROPHYSIOLOGY UPLINK+ WORKFLOW DATA PRIVACY HELP FAQ INTRODUCTION. Welcome to UpLink+, the NETRI Cloud application that enables you to process your compartmentalized electrophysiological recordings using NETRI NeuroFluidics™ MEA Architectures. With UpLink+ you will be able to explore the effects metrics of each compartment, by : • Processing CSV and SPK files
- [Leadership](https://netri.com/leadership/) - TEAMS & CAREERS. EXECUTIVE TEAMS STRATEGIC ADVISORY BOARD CAREERS MULTIDISCIPLINARY TEAMS. With more than 30 collaborators, including 12 PhDs part of a mutlidisciplinary team (engineering, biology and digital), we are located in Lyon (France) with 1100 m² of production units. Audacity, Agility, Passions and Team Spirit: the four fundamental pillars of NETRI. It is our
- [Terms & Conditions](https://netri.com/terms-conditions/) - General terms and conditions of saleMay 2026DefinitionsIn these General Terms and Conditions of Sale (“T&Cs”), terms beginning with a capital letter, whether used in the singular or plural, shall have the meaning set out below. Other terms retain their ordinary meaning.“Affiliate” means any entity which controls, is controlled by, or is under common control with
- [STANDARDIZED MICROPHYSIOLOGICALS SYSTEMS](https://netri.com/standardized-microphysiologicals-systems/standardized-microphysiologicals-systems-applications/) - STANDARDIZED MPS APPLICATIONS. INNERVATION. THE ONLY COMPARTMENTALIZED ELECTROPHYSIOLOGY PLATFORM. NETRI devices enable functional innervation of any cell types through its unique compartmentalized electrophysiology platform, NeoBento, designed to recreate physiologically relevant innervated in vitro models. By spatially isolating distinct cell populations while maintaining controlled connectivity through, the system allows precise modulation and recording of neuronal activity
- [Neurology](https://netri.com/neurons-as-a-sensor-applications/neurology/) - NEUROLOGY. ALS NEUROTOXICITY SAFETY DIS POTENTIAL APPLICATIONS AMYOTROPHIC LATERAL SCLEROSIS. DE-RISK EFFICACY & SAFETY BEFORE THE CLINIC. Benefits. By providing human-relevant functional data on patient-derived motor neurons, NETRI ALS platform enhances clinical risk assessment. It allows early detection of compound efficacy, enabling better prediction of therapeutic benefit and safety, guiding dose selection, and reducing the
- [OFFERINGS](https://netri.com/offerings/) - OUR OFFERS. STANDARD MICROPHYSIOLOGICAL SYSTEM NAAS PLATFORM STANDARD MICROPHYSIOLOGICAL SYSTEMS. Because it takes time to establish a biological model, we help you by providing : • Devices. • Metrics extraction and analytics on-line software. • Full Tech Transfer: Training & Support Service. • Full Tech Transfer: Training, Protocols & Support Service. OUR MPS PACKS. DISCOVERY
- [WETWARE](https://netri.com/wetware/) - WETWARE. NEURONAL CELLS NEURONAL ASSOCIATED CELLS IMMUNE CELLS OTHER CELL TYPES 3D CELL CULTURES WETWARE APPROACH. At NETRI, we have developed and validated a comprehensive portfolio of human-relevant cell models specifically optimized for our organs on chip platforms and associated standardized operating protocols. Our wetware approach integrates a wide range of cell types, each functionally
- [Neurotoxicology](https://netri.com/neurons-as-a-sensor-applications/neurotxicology/) - NEUROTOXICOLOGY. NEUROTOXICITY CHEMICAL SAFETY. DE-RISK FUNCTIONAL ALTERATIONS EFFECTS BEFORE THE CLINIC. Benefits. By providing human-relevant, compartmentalized neuronal readouts of compound-induced neurotoxicity , NETRI Neurotoxicity chemical safety platform strengthens clinical risk assessment. It enables early detection of functional alterations and dose-dependent effects, supporting safer chemical or pesticide evaluation, guiding regulatory decisions, and reducing reliance on animal
- [Dermatology](https://netri.com/neurons-as-a-sensor-applications/dermatology/) - DERMATOLOGY. SKIN MODEL POTENTIAL APPLICATIONS SKIN MODEL. DE-RISK ITCHING AND DESENSITIZING BEFORE CLINIC. Benefits. By providing human-relevant, functional readouts of nerve-ending activation and pruritic pathways, NETRI Skin model improves clinical risk assessment. It enables early evaluation of anti-itch or desensitizing compounds, predicts potential adverse effects on sensitive skin, and supports safer candidate selection while reducing
- [Oncology](https://netri.com/neurons-as-a-sensor-applications/oncology/) - ONCOLOGY. DIPN EMETIC & NAUSEA RESPONSE POTENTIAL APPLICATIONS DRUG INDUCED PERIPHERAL NEUROPATHY. DE-RISK NEUROTOXICITY BEFORE THE CLINIC. Benefits. By measuring functional effects directly in human neurons, NETRI supports pharma teams select safer leads, optimize payloads and dosing strategies, and preserve efficacy while minimizing neuropathy-driven dose reductions or discontinuations. Description. Create a high throughput microscope-free platform
- [NEURONS AS A SENSOR APPLICATIONS.](https://netri.com/neurons-as-a-sensor-applications/) - NEURONS AS A SENSOR APPLICATIONS. NaaS DEFINITION ONCOLOGY DERMATOLOGY NEUROLOGICAL DISORDERS NEUROTOXICITY NEURONS AS A SENSOR PLATFORM. A SUITE OF TOOLS FOR A UNIQUE SELLING PROPOSITION. NETRI leverages neurons as highly sensitive biological sensors capable of encoding complex physiological and pathological stimuli into quantifiable electrophysiological signals. Through its compartmentalized platform, neurons interface with peripheral or
- [OUR COMPANY](https://netri.com/our-company/) - OUR COMPANY. VERSION FRANCAISE VALUE COMPASS CORPORATE SOCIAL RESPONSIBILITY (CSR) KEY FIGURES & TIMELINE A TECHBIO COMPANY. Based on 10 years of work in academic research, NETRI was founded in June 2018 in Lyon. Considered as a TechBio, NETRI develops so-called organs-on-chip technologies that, coupled with Artificial Intelligence, predict the human effect of a drug
- [HARDWARE](https://netri.com/hardware/) - HARDWARE. ECM BIOMEMESYS VASCULARIZATION INNERVATION ECM BIOMIMESYS® . COMPOSITION. BioMIMESYS® is a biofunctionalized hydro-scaffold designed to reproduce the key biochemical, structural, and mechanical properties of native extracellular matrix (ECM) . The platform is based on a hyaluronic acid backbone functionalized with adhesion ligands and structural proteins such as collagen, combined with peptide-based cross-linkers to form
- [Software](https://netri.com/software/) - SOFTWARE. UPLINK NaaS HUB UPLINK PLUS. DESCRIPTION. UpLink Plus is NETRI’s electrophysiology analytics software designed to process and structure recordings generated from compartmentalized neuronal microfluidic devices. The software interfaces with the Axion BioSystems’s Maestro PRO or EDGE environment and enables automated analysis of neuronal activity signals across multiple compartments and microchannels. By leveraging NETRI’s device
- [THE TECHNOLOGY BEHIND](https://netri.com/the-technology-behind/) - THE TECHNOLOGY BEHIND. HARDWARE, WETWARE & SOFTWARE. THREE COMPLEMENTARY CORE PILLARS. NETRI’s technology is built on the convergence of three complementary core pillars: Hardware, Wetware, and Software. Our proprietary microfluidic hardware enables innervation, vascularization and ECM integration. This is combined with advanced wetware, including standardized neuronal and innervated tissue models, co-cultures, and organoid-based systems. Together
- [INDUSTRY ALLIANCE FOR MICROPHYSIOLOGICAL SYSTEMS](https://netri.com/industry-alliance-for-microphysiological-systems/) - INDUSTRY ALLIANCE FOR MICROPHYSIOLOGICAL SYSTEMS (IAMPS). MISSION KEY PRIORITIES AMBITION MEMBERS NETRI AT THE INITIATIVE AND PRESIDENCY OF IAMPS. NETRI has played a key role in the creation and development of IAMPS from its earliest stages. Prior to the formal establishment of the association, NETRI actively contributed to the discussions and community efforts aimed at
- [French Organoids & Organs-on-chip Initiative](https://netri.com/french-organoids-organs-on-chip-initiative/) - FRENCH ORGANOIDS & ORGANS-ON-CHIP INITIATIVE (F3OCI). A STRATEGIC SECTOR CO-PILOT INITIATIVES NETRI AT THE HEART OF THE F3OCI INITIATIVE. NETRI's active involvement in structuring the O&OoC sector confirms its role as a leader in innovative healthcare technologies. Thanks to its expertise and strategic partnerships, the company is helping to position France as a major player
- [TEMPLATE 2026](https://netri.com/template-2026/) - LOREM IPSUM. SIMPLY DUMMY TEXT PRINTING TYPESETTING BLOC PHOTO + TEXTE : TITLE. SUB-TITLE. Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type
- [NETRI](https://netri.com/prensentation-netri/) - NETRI. NOS VALEURS RESPONSABILITÉ SOCIALE DES ENTREPRISES (RSE) CHIFFRES CLÉS & CHRONOLOGIE UNE ENTREPRISE TECHBIO. Basé sur 10 années de recherche universitaire, NETRI a été fondée en juin 2018 à Lyon. Considérée comme une TechBio, NETRI développe des technologies dites « d'organes sur puce » qui, associées à l'intelligence artificielle, permettent de prédire les effets
- [Compartmentalized MEA](https://netri.com/compartmentalized-mea/) - COMPARTMENTALIZED ELECTROPHYSIOLOGY. NETRI has developed compartmentalization technologies to organize cultures thanks to its microchannels, and electrophysiology technologies to extract data from neurons thanks to its strategic partnership with Axion BioSystems (MEA). COMPARTMENT & CULTURE. NeoBento™. All NETRI''s organs-on-chip devices are in NeoBento™ format. Designed for full compatibility with industry-standard handling systems, imaging platforms, and readout
- [Wetware](https://netri.com/wetware-3/) - WETWARE. NEURONAL CULTURES. 2D Cultures. 2D neuronal cultures are derived from human induced pluripotent stem cells (hiPSC) and include the main functional subtypes. These co-cultures are designed to recreate physiologically relevant neuronal circuits in NETRI's compartmentalized microfluidic devices. • Glutamatergic Neurons. • GABAergic Neurons. • Motor Neurons. • Sensory Neurons. • Dorsal Horn Neurons. •
- [ORGANOIDS & ORGANS-ON-CHIP INITIATIVES](https://netri.com/organoids-organs-on-chip-initiatives/) - ORGANOIDS & ORGANS-ON-CHIP INITIATIVES. FRENCH & EUROPE INITIATIVES. NETRI is actively engaged in initiatives advancing organoid and organs-on-chip technologies, including Industry Alliance for Microphysiological Systems (IAMPS) and French Organoids & Organs-on-Chip Initiative (F3OCI). Through these initiatives, NETRI contributes to the structuring and adoption of New Approach Methodologies (NAMs) by actively engaging with regulatory authorities, governmental
- [Immunology](https://netri.com/neurons-as-a-sensor-applications/immunology/) - IMMUNOLOGY. INFLAMMATORY PAIN POTENTIAL APPLICATIONS INFLAMMATORY PAIN. Description. Create a platform to capture the influence of immune cells (such as macrophages, mast cells, dendritic cells, and T cells…) on pain pathways and neuronal excitability by capturing interactions between immune cells and neurons. Readouts. • MEA recordings & Digital Signatures. • ELISA. • Imaging. Advantages. •
- [Who we are?](https://netri.com/who-we-are/) - OUR COMPAGNY. VERSION FRANCAISE A TECHBIO COMPAGNY. Based on 10 years of work in academic research, NETRI was founded in June 2018 in Lyon. Considered as a TechBio, NETRI develops so-called organs-on-chip technologies that, coupled with Artificial Intelligence, predict the human effect of a drug candidate. Located in the heart of Lyon's Gerland Biodistrict, NETRI
- [Why NETRI?](https://netri.com/why-netri-2/) - WHY NETRI? THE CLINICAL PIPELINE PROBLEM. A long, costly and risky process. Drug development is a long, costly and risky process. Advancing a drug candidate to clinical trials is rigorously validated at the preclinical stage. •15 yers of development. • $2B for each new drug. • 90% clinical drug development failure rate with 50% of
- [NEURONS-BASED INTELLIGENCE PLATFORMS](https://netri.com/neurons-based-intelligence-platforms/) - NEURON-BASED INTELLIGENCE PLATFORMS. RESEARCH & LICENSING AGREEMENT LEVEL. CO-DEVELOPMENT. Initialisation of NaaS biology platform and NaaS Model for a target application at NETRI Lab or directly in your Lab. UPSCALING. Build up of Digital NaaS model through Training Library of 100s of reference compounds. LICENSING. Transfer of methodology, devices and predictive model capabilities to client.
- [Media Center](https://netri.com/media-center/) - MEDIA CENTER. 150+ resources with our organs-on-chip and digital library technologies. 70+ Publications 10+ Use Cases 20+ Webinars 15+ Protocols Videos Webinars 19 Videos [2025] Webinar F3OCI - Livre Blanc Organoïdes et Organes sur puce 0:16 [2025] Webinar #2 - Profiling Pharmacokinetics (PK) In A Microfluidic Platformation Award. 0:16 [2025] Webinar #1 - NeuroFluidics Care:
- [Resources Hub](https://netri.com/resources-hub-3/) - RESOURCES HUB. 150+ resources with our organs-on-chip and digital library technologies. 70+ Publications 10+ Use Cases 20+ Webinars 15+ Protocols Publications Bessy, T.; Lambert, T.; Dubuisson, L.; Batut, A.; Azema, A.; Baquerre, C.; Ponomarenko, A.; Roux, S.; Ftaich, N. and Honegger, T. (2025). The NaaS Methodology applied to modeling chemotherapy-induced peripheral neuropathy with human hiPSC
- [BioMIMESYS - ExtraCellular Matrix](https://netri.com/biomimesys-extracellular-matrix/) - BIOMIMESYS® - EXTRACELLULAR MATRIX. 3D CELLULAR ASSAYS. What is BIOMIMESYS® hydroscaffold? BIOMIMESYS® is a unique groundbreaking 3D cell culture technology which associates the behavior of a solid scaffold and of a hydrogel which provide a cell culture microenvironment reproducing all aspects of human tissues, including matrix architecture, cellular organization, cell-cell and cell-matrix interactions. Depending on
- [The NaaS Methodology applied to modeling chemotherapy-induced peripheral neuropathy with human hiPSC neurons](https://netri.com/the-naas-methodology-applied-to-modeling-chemotherapy-induced-peripheral-neuropathy-with-human-hipsc-neurons/) - THE NaaS METHODOLOGY APPLIED TO MODELING CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY WITH HUMAN hiPSC NEURONS. Thomas Bessy1*, Théo Lambert1*, Louise Dubuisson1, Aurélie Batut1, Audrey Azema1, Camille Baquerre1, Alexandre Ponomarenko1, Serge Roux1, Najate Ftaich1, Thibault Honegger1 1 NETRI, Lyon, France * these authors contributed equally Under review ABSTRACT. The Neuron-as-a-Sensor (NaaS) methodology is a human-relevant platform designed to
- [Hardware and Software](https://netri.com/hardware-and-software/) - HARDWARE & SOFTWARE. NETRI has developed hardware and software to co-culture different cell types and analyze electrophysiological recording thanks to its microchannels, and utility software. All NETRI hardware products are available worldwide through its network of distributors. DISTRIBUTORS HARDWARE: NEUROFLUIDICS™ MEA. For 2D Cell Culture. NETRI’s DuaLink, DuaLink Shift and TriaLink, are specially designed to
- [Neurotoxicology](https://netri.com/food-safety-program/) - NEUROTOXICOLOGY. NEUROTOXICITY. Brain Organoid-on-chip. NETRI has successfully demonstrated that cerebral organoids grow more consistently in NETRI's 3D platforms, providing a more reliable starting point for toxicity testing. Using H2O2 as a proof of concept, NETRI has also developed decision tree algorithms to perform noninvasive quality control during culture and explore the impact of toxins, enhancing
- [Neurological Disorders Program](https://netri.com/neurological-disorders-program/) - NEUROLOGICAL DISORDERS PROGRAM. CENTRAL NERVOUS SYSTEM RELATED APPLICATIONS. Healthy CNS co-culture. NETRI has established a healthy cultures and co-cultures of glutamatergic and/or GABAergic neurons as a foundational system, particularly with the BIODIAMOND project. This base model allows to explore and build upon neuronal interactions, providing a robust platform to study the effects of various compounds
- [Dermatology Program](https://netri.com/dermatology-program/) - DERMATOLOGY PROGRAM. NaaS FOR DERMATOLOGY APPLICATIONS. Dermatology-related Pain. NETRI has established an in vitro platform using hiPSC-derived sensory neurons suitable to assess the efficacy of compounds of interest in dermocosmetic such as pain management. • WS12 quantification for TRPM8 characterization. • Temperature effect. GET MORE DATA IRRIGATED SKIN. Endothelial Cells & Keratinocytes. NETRI has established
- [Immunology Program](https://netri.com/immunology-program/) - IMMUNOLOGY PROGRAM. INFLAMMATORY. Inflammation & Neuronal Function. Inflammation plays a central role in the regulation of neuronal signalling. Cytokines and immune mediators can disrupt neural communication, shaping pain pathways and complicating the development of effective therapies. NETRI’s organ-on-chip platforms recreate human neuro-immune interactions in vitro. By modeling the influence of immune cells (such as macrophages,
- [Oncology Program](https://netri.com/oncology-program/) - ONCOLOGY PROGRAM. PAIN MANAGEMENT. Chemotherapy-Induced Peripheral Neuropathy. 60-80% of oncology patients suffer from peripheral neuropathic pain during treatment. In 20-40% of patients treated, the pain becomes chronic. To address this concern, NETRI is establishing an in vitro CIPN platform using hiPSC-derived sensory neurons in an organs-on-chip devices compatible with MEA. This platform enables functional analysis
- [The way we work](https://netri.com/the-way-we-work/) - THE WAY WE WORK. Neuron-as-a-Sensor is a carefully streamlined method for assessing novel compounds with early, enhanced predictivity. It is based on the realization that neurons are the natural bio-digital sensors of the body, and that their sensing capability can be harnessed universally using compartmentalized electrophysiology . Practicaly, NaaS is comprized of a suite of
- [Downloads](https://netri.com/downloads/) - DOWNLOADS. This page is dedicated to downloading our software. CONTACT SUPPORT TEAM NETRI UpLink. NETRI UpLink installer v1.4.1 - September 2025. Changelog: 1. User Interface updated for Windows 11 compatibility. 2. Progress bar recalibrated: goes from 0% to 50% during AxIS Navigator computation and 50% to 100% during report filling and raster plot generation. 3.
- [Neurons-as-a-Sensor](https://netri.com/neurons-as-a-sensor/) - NEURONS-AS-A-SENSOR (NaaS) APPROACH. Neuron-as-a-Sensor is a carefully streamlined method for assessing novel compounds with early, enhanced predictivity. It is based on the realization that neurons are the natural bio-digital sensors of the body, and that their sensing capability can be harnessed universally using compartmentalized electrophysiology . Practicaly, NaaS is comprized of a suite of automated
- [Downloads-link-2025](https://netri.com/downloads-link-2025/) - Downloads New - NETRI About WordPressAbout WordPressGet InvolvedWordPress.orgDocumentationLearn WordPressSupportFeedbackNETRIDashboardPluginsThemesWidgetsMenusCustomizeImroz Theme Options88 updates available00 Comments in moderationNewPostMediaPageTemplatePortfolioMapProtected AreaPassword ListTimeline StoriesUserWPFormsCopy thisEdit Protected Area InsightsWPFormsAll FormsAdd New FormPaymentsSettingsGeneralEmailCAPTCHAValidationPaymentsIntegrationsGeolocationAccess ControlMiscToolsImportExportEntry AutomationSystem InfoScheduled ActionsView AllCompleted ActionsFailed ActionsPending ActionsPast Due ActionsLogsCode SnippetsCommunityHelp DocsUpgrade to ProSEO!Notifications SEO PreviewNEW!Analyze this pageGoogle Page Speed TestGoogle Rich Results TestSchema.org ValidatorInbound LinksFacebook DebuggerLinkedIn Post InspectorHTML
- [Newsletter](https://netri.com/newsletter-2/) - We're excited and proud to launch our new quarterly newsletter! To make sure you receive it, please sign up.
- [Our distributors](https://netri.com/our-distributors/) - Whether you're in America, Europe, or Asia, discover our collections of high-throughput microfluidic devices through our global network of distributors.
- [BioDiamond](https://netri.com/biodiamond/) - BIO-DIAMOND Features. BIO-DIAMOND is a pilot project demonstrating the benefits of organs-on-chip to accelerate the time-to-market of drug candidates in the "discovery" and "pre-clinical" phases in the fields of Alzheimer's, Parkinson's and Amyotrophic Lateral Sclerosis (ALS). The project also aims to create France's first industrial biobank of human stem cells dedicated to the commercialization of
- [Corporate Social Responsibility](https://netri.com/csr-rse/) - CORPORATE SOCIAL RESPONSIBILITY (CSR). OUR CSR COMMITMENT: INNOVATING WITH PURPOSE, ACTING WITH RESPONSIBILITY. At NETRI, we believe that technological innovation must go hand in hand with strong human and societal values. Our ambition: to combine scientific excellence, respect for people, and environmental stewardship. As a pioneer in Organs-on-Chip technologies, NETRI is committed to developing ethical,
- [contact us](https://netri.com/contact-us/) - Phone Number +33 (0)4 87 65 75 63 Email Address contact@netri.com Our Location 76 Rue Georges Gouy, 69007, Lyon , FRANCE How can we help you? Enter the answer to verify that you are not a robot : 99-1
- [Qui sommes-nous ?](https://netri.com/qui-sommes-nous/) - QUI SOMMES-NOUS? PRESENTATION DE NETRI. Une nouvelle échelle. Basé sur 10 ans de travail dans la recherche académique, NETRI a été fondé en juin 2018 à Lyon. Considérée comme une TechBio, NETRI développe des technologies dites d'organes sur puce qui, couplées à l'Intelligence Artificielle, permettent de prédire l'effet clinique d'un candidat médicament. Situé au cœur
- [Blog](https://netri.com/blog/) - Stay up to date with NETRI ews.

## Portfolios

- [DUALINK MEA](https://netri.com/portfolio/dualink-mea-2/) - Co-culture & enhanced axonal projection rate With the DuaLink MEA microfluidic chip, the microchannels, NeoBento™ and MEA compatibility technologies are combined in a single microfluidic chip, to provide an unmatched user experience combined with an functional co-culture recording. Co-culture of different cell types and its functional activity recording Discontinuous connectivity by microchannels tunnels technology 3 compartments integrated on Axion Biosystems
- [TRIALINK MEA](https://netri.com/portfolio/trialink-mea/) - Functional tri-culture recording With the TriaLink™ MEA microfluidic chip, the microchannels, NeoBento™ and MEA compatibility technologies are combined in a single microfluidic chip, to provide an unmatched user experience combined with a discontinuous connectivity and neuronal functional analysis. Functional activity recording Tri-culture Discontinuous connectivity by microchannels tunnels technology 3 compartments crowded on MEA plat for independant 3 different cell type cultures 8
- [TRIALINK ULTRA](https://netri.com/portfolio/trialink-ultra/) - Tri-culture & continious connectivity With the TriaLink™ microfluidic chip, the microchannels and NeoBento™ technologies are combined in a single microfluidic chip, to provide an unmatched user experience combined with the ability to culture up to 3 different cell types. Tri-culture Continuous connectivity by microchannels grooves technology 3 compartments for independant 3 different cell type cultures 8 or 16 microfluidic chips per NeoBento™
- [TRIALINK](https://netri.com/portfolio/trialink/) - Tri-culture With the TriaLink™ microfluidic chip, the microchannels and NeoBento™ technologies are combined in a single microfluidic chip, to provide an unmatched user experience combined with the ability to culture up to 3 different cell types. Tri-culture Discontinuous connectivity by microchannels tunnels technology 3 compartments for independant 3 different cell type cultures 8 or 16 microfluidic chips per NeoBento™ GET A QUOTE
- [DUALINK DELTA ULTRA](https://netri.com/portfolio/dualink-delta-ultra/) - Growth kinetics With the DuaLink™ Delta Ultra microfluidic chip, the microchannels and NeoBento™ technologies are combined into a single microfluidic chip, to provide an unmatched user experience combined with an enhanced growth kinetics. Enhanced growth kinetics Triangular shape with microchannels of different length Continuous connectivity by microchannels grooves technology 3 compartments: 1 for cell culture, 1 for fluidic isolation and 1 to monitor
- [DUALINK SHIFT MEA](https://netri.com/portfolio/dualink-shift-mea/) - Functional synaptic recording With the DuaLink™ Shift MEA microfluidic chip, the microchannels, NeoBento™ and MEA compatibility technologies are combined in a single microfluidic chip, to provide an unmatched user experience combined with physiological synaptic compartmentalization and neuronal functional analysis. Functional synapse recording in the middle channel Asymmetrical shape with microchannels of different length (shorter length between the first and second channel than between
- [DUALINK SHIFT](https://netri.com/portfolio/dualink-shift/) - Synaptic isolation With the DuaLink™ Shift microfluidic chip, the microchannels, and NeoBento™ technologies are combined in a single microfluidic chip, thus providing an unmatched user experience combined with physiological synaptic compartmentalization. Synapse isolation in the middle channel Asymmetrical shape with microchannels of different length (shorter length between the first and second channel than between the second and third channel) Discontinious connectivity
- [DUALINK MEA](https://netri.com/portfolio/dualink-mea/) - Co-culture & enhanced axonal projection rate With the DuaLink MEA microfluidic chip, the microchannels, NeoBento™ and MEA compatibility technologies are combined in a single microfluidic chip, to provide an unmatched user experience combined with an functional co-culture recording. Co-culture of different cell types and its functional activity recording Discontinuous connectivity by microchannels tunnels technology 3 compartments crowded on MEA plate:
- [DUALINK ULTRA](https://netri.com/portfolio/dualink-ultra/) - Co-culture & enhanced axonal projection rate With the DuaLink Ultra microfluidic chip, the microchannels and NeoBento™ technologies are combined in a single microfluidic chip, to provide an unmatched user experience combined with an enhanced axonal projection rate. Co-culture of different cell types Enhanced axonal projection and time to results Continuous connectivity by microchannels grooves technology 3 compartments : 2 for cell culture
- [DUALINK](https://netri.com/portfolio/dualink/) - Co-culture & fluidic isolation With the DuaLink microfluidic chip, microchannels tunnels and HT format NeoBento technologies are combined in a single chip to provide an unparalleled user experience combined with an enhanced fluidic isolation. Co-culture of different cell types Compartmentalization Fluidic isolation Discontinious connectivity by microchannels tunnels technology 3 compartments : 2 for cell culture

## Timeline Stories

- [2023](https://netri.com/cool_timeline/2023/) - Introduced the NeuroFluidics™ MEA Line , co-developed with Axion BioSystems, along with UpLink utility software for MEA metric evaluation. Introduced organs-on-chip kits in three packages: Models OoC Kits, Starter OoC Kits and Training OoC Kits. Introduced Pain & Injury model with a specific use case about Chemotherapy Induced Peripheral Neuropathy and Innervated skin model with co-culture of hiPSC sensory neurons and primary keratinocytes.

## Categories

- [Uncategorized](https://netri.com/category/uncategorized/)
- [News](https://netri.com/category/news/) - News
- [NETRI News](https://netri.com/category/netri-news/)
- [Publications](https://netri.com/category/publications/)
- [Neurofluidics Literature](https://netri.com/category/neurofluidics-literature/)
- [In the press](https://netri.com/category/in-the-press/)
- [Latest Publications](https://netri.com/category/latest-publications/)

## Tags

- [biotuesdays](https://netri.com/tag/biotuesdays/)
- [presentation](https://netri.com/tag/presentation/)
- [innovation clinique](https://netri.com/tag/innovation-clinique/)
- [paper](https://netri.com/tag/paper/)
- [Neurofluidics-literature](https://netri.com/tag/neurofluidics-literature/)

## Portfolio Categories

- [NEUROFLUIDICS™ LINE](https://netri.com/portfolio-cat/neurofluidics-line/)
- [2-Cell Culture](https://netri.com/portfolio-cat/2-cell-culture/)
- [3-Cell Culture](https://netri.com/portfolio-cat/3-cell-culture/)
- [Enhanced Axonal Projection](https://netri.com/portfolio-cat/enhanced-axonal-projection/)
- [Synaptic Isolation](https://netri.com/portfolio-cat/synaptic-isolation/)
- [MEA Electrophysiology](https://netri.com/portfolio-cat/mea-electrophysiology/)
- [Growth Kinetics](https://netri.com/portfolio-cat/growth-kinetics/)